Market

Business Communications Company, Inc.; B-119/ Cell Therapy and Tissue Engineering: Emerging Products (www.prgguide.com)

Anna Crull/Jones, Buscom:
"Innovative research has led to the commercialization of new products (... in the rapidly growing and changing biotechnology field). In a short period of time, competing bioreactor equipment to manufacture developing products has emerged ... some of it has created its own market niche.
The bioreactor market has now gotten over the hype of alternative technologies. One now sees specific technologies firmly established for specific end uses. There are also a host of emerging uses for bioreactor technology ... As research turns into commercialization, the bioreactor market should certainly be watched for potential dramatic growth. However, even in this pre-commercialization stage, the great demand for cost efficient research materials has created niches within the bioreactor market. ...

Bioreactors have become a much more accepted part of bioremediation. ... There is also important bioreactor research going on in the tissue engineering field. The commercialization of tissue engineering will probably mean a significant new use for bioreactor technology." (www.buscom.com/biotech/C-086R.html)

Frost & Sullivan: U.S. Cell Therapy Markets:
"...a burgeoning number of products newly introduced or being developed through the overlapping technologies of cell therapy and tissue engineering. These products target virtually every organ system of the body and many of the major ills that afflict mankind ... their market potential is enormous ... a reasonably large portion of that potential is likely to be realized within the next decade." (www.prgguide.com)